EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

“Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection

Eric Dinnerstein

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-04 · 18 (2)

DOI: 10.1002/dad2.70373 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 17.06.2026. Verfasst von Eric Dinnerstein. Beteiligte Einrichtung: UT Tyler Neurology Department The University of Texas Tyler Dementia Center Tyler Texas USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The approval of lecanemab and donanemab represents a watershed moment in Alzheimer Disease (AD) treatment, yet clinicians face a novel challenge: guiding patients through treatment selection when head‐to‐head comparative data are absent. When confronted with the question “What would you do if you were me?”, clinical providers must balance evidence‐based medicine with the therapeutic alliance. This perspective examines the ethical, practical, and relational dimensions of responding to personal preference queries in the context of anti‐amyloid immunotherapy selection, offering a framework for authentic engagement that honors both professional boundaries and patient‐centered care.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's disease (AD)anti‐amyloid immunotherapyclinical equipoisedonanemablecanemabmedical ethicspatient‐centered carephysician‐patient relationshipshared decision‐makingtreatment selection

Autor:innen und Institutionen

  • UT Tyler Neurology Department The University of Texas Tyler Dementia Center Tyler Texas USA.

Zitieren

APA

Dinnerstein, E. (2026). “Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(2). https://doi.org/10.1002/dad2.70373

Vancouver

Dinnerstein E. “Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(2). doi:10.1002/dad2.70373

BibTeX
@article{Dinnerstein2026,
  author = {Dinnerstein, Eric},
  title = {“Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2026},
  volume = {18},
  number = {2},
  doi = {10.1002/dad2.70373}
}
Kostenlos starten →